Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Comparison with thymosin peptides TB-500 , a synthetic fragment of thymosin beta-4, promotes tissue repair through different mechanisms than copper peptides
Pain improves before tissue fully rebuilds, creating a false sense of recovery
[Download Your Free Stack Card] Loading phase (weeks 1-4): - BPC-157: 250-500mcg subcutaneous, twice daily (morning and evening) - TB-500: 2.0-2.5mg subcutaneous, twice weekly (example: Monday and Thursday) - Total BPC-157 per day: 500-1000mcg - Total TB-500 per week: 4.0-5.0mg Maintenance phase (weeks 5-8+): - BPC-157: 250mcg subcutaneous, once daily - TB-500: 2.0-2.5mg subcutaneous, once weekly - Continue until healing goals are met or as directed by your provider Injection details: - Both peptides are injected subcutaneously in the abdomen - BPC-157 can optionally be injected near the injury site (subcutaneous) - TB-500 works systemically regardless of injection location - Rotate injection sites to prevent tissue irritation - Use insulin syringes for accurate dosing Reconstitution: Both peptides come as lyophilized powder
Neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease show preliminary preclinical evidence of BPC-157 benefits
Many research vials are happier near 2-3 ml
